Coronavirus channel feed – Endpoints News

Coronavirus channel feed

FDA goes on high alert as coronavirus raises threat to drug manufacturing and clinical trials grind to a halt

6 years ago

AstraZeneca's Chinese investment bank partner raises $229M for its own new fund — and it's all about the coronavirus

6 years ago

Coronavirus outbreak clouds AstraZeneca's Q4 results and 2020 outlook

6 years ago

Elanco grabs $140M in deal with French pharma company; Another company announces a coronavirus vaccine hunt

6 years ago

Coronavirus update: A summit in Geneva, WuXi hunts antibodies and J&J partners on a vaccine search

6 years ago

A Chinese company is already mass producing Gilead's experimental coronavirus drug

6 years ago

The Wuhan coronavirus has an official name: COVID-19; Revolution Medicines upsizes IPO terms

6 years ago

Moderna eyes $500M secondary offering on upbeat coronavirus vaccine update — almost ready for the clinic

6 years ago

Bill Gates pitches in on coronavirus R&D and containment efforts with $100M commitment

6 years ago

EMA, FDA and WHO prep for new coronavirus treatments, IVDs

6 years ago

Gilead surges wildly as world scrambles to counter a likely coronavirus pandemic while GSK pitches in on vaccine R&D campaign

6 years ago

CureVac jumps into coronavirus vaccine race; EMA backs raft of drugs, including Novo Nordisk, Esperion compounds

6 years ago

FDA outlines product development process to combat Wuhan coronavirus

6 years ago

AbbVie donates $1M+ of the HIV drug that China is now recommending for coronavirus treatment

6 years ago

Gilead dusts off a failed Ebola drug as coronavirus spreads; Exelixis boasts positive Ph I/II data

6 years ago

Wuhan virus outbreak triggers inevitable small-biotech rally

6 years ago

First page Previous page 58 59 6061